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Contribution of a Low-Barrier Hydrogen Bond to  
Catalysis Is Not Significant in Ketosteroid 
Isomerase 
Do Soo Jang1,2,7, Gildon Choi3,7, Hyung Jin Cha1,4,7, Sejeong Shin5, Bee Hak Hong1,2, Hyeong Ju Lee6,
Hee Cheon Lee6, and Kwan Yong Choi1,*
 
 
Low-barrier hydrogen bonds (LBHBs) have been proposed 
to have important influences on the enormous reaction rate 
increases achieved by many enzymes. 5-3-ketosteroid 
isomerase (KSI) catalyzes the allylic isomerization of 5-3-
ketosteroid to its conjugated 4-isomers at a rate that ap-
proaches the diffusion limit. Tyr14, a catalytic residue of KSI, 
has been hypothesized to form an LBHB with the oxyanion 
of a dienolate steroid intermediate generated during the 
catalysis. The unusual chemical shift of a proton at 16.8 
ppm in the nuclear magnetic resonance spectrum has been 
attributed to an LBHB between Tyr14 O and C3-O of equi-
lenin, an intermediate analogue, in the active site of D38N 
KSI. This shift in the spectrum was not observed in 
Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N mutant KSIs 
when each mutant was complexed with equilenin, suggest-
ing that Tyr14 could not form LBHB with the intermediate 
analogue in these mutant KSIs. The crystal structure of 
Y30F/Y55F/Y115F/D38N-equilenin complex revealed that the 
distance between Tyr14 O and C3-O of the bound steroid 
was within a direct hydrogen bond. The conversion of LBHB 
to an ordinary hydrogen bond in the mutant KSI reduced the 
binding affinity for the steroid inhibitors by a factor of 8.1-11. 
In addition, the absence of LBHB reduced the catalytic activ-
ity by only a factor of 1.7-2. These results suggest that the 
amount of stabilization energy of the reaction intermediate 
provided by LBHB is small compared with that provided by 
an ordinary hydrogen bond in KSI. 
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INTRODUCTION
 
One of the fundamental questions in enzyme catalysis is how an 
enzyme can stabilize a reaction intermediate and transition state 
during enzymatic reaction to accelerate the enzyme-catalyzed 
reaction rate over the non-enzymatic one. The low-barrier hydro-
gen bond (LBHB) has been invoked to explain a large amount of 
the energy that is required to stabilize the intermediate in many 
enzyme reactions (Gerlt and Gassman, 1993). An LBHB has 
been hypothesized to occur when the distance between the two 
heteroatoms is less than the sum of their van der Waals radii and 
the pKa values of the hydrogen bond partners are similar to each 
other, so that they exhibit a covalent character that is absent in an 
ordinary hydrogen bond (Cleland and Kreevoy, 1994; Frey et al., 
1994). The covalent character of LBHB could increase its 
strength; i.e., its H of formation increase by as much as 10-20 
kcal/mol (Cleland et al., 1998; Zhang, 2007). Among the conven-
tional physicochemical parameters used to characterize LBHBs, 
the unusual chemical shift of proton nuclear magnetic resonance 
(NMR) near 16 to 20 ppm in the downfield region is regarded as 
the clearest evidence for the presence of LBHBs in proteins 
(Cleland and Kreevoy, 1994; Frey et al., 1994). However, the 
degree to which LBHB contributes to catalysis is controversial 
(Ash et al., 1997; Perrin, 2010; Pollack et al., 1999; Schutz and 
Warshel, 2004). A theoretical calculation led to a conclusion that 
LBHB cannot stabilize the transition-state more than can ordinary 
hydrogen bonds (Warshel and Papazyan, 1996). Experimental 
evidence in model compounds suggested that LBHBs might not 
contribute additional energy to the hydrogen bond between a 
hydrogen bond donor and acceptor that have matched pKas 
(Shan et al., 1996). 

5
-3-ketosteroid isomerase (KSI) catalyzes the allylic 
rearrangement of the 5,6 double bond of 5-3-ketosteroids to 
the 4,5 position, and accelerates the reaction by a factor of 1011 
compared to the nonenzymatic reaction by an intramolecular 
proton transfer (Fig. 1) (Pollack, 2004). Two bacterial KSIs, one 
from Comamonas testosteroni and one from Pseudomonas 
putida have been studied to understand the enzyme-catalyzed 
heterolytic C-H bond cleavage that occurs in a wide variety of 
biological reactions (Gerlt et al., 1991). In the reaction catalyzed 
by KSI, Tyr14 and Asp99 are thought to have critical functions 
in stabilizing a dienolate intermediate by forming LBHB or ordi-
nary hydrogen bonds with the oxyanion of the intermediate 
(Cho et al., 1998; Kim et al., 1997a). The 1H NMR spectrum of 
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KSI complexed with equilenin (i.e., an intermediate analogue in 
the reaction) shows a highly deshielded proton resonance near 
17 ppm, which has been regarded as compelling evidence for 
the involvement of LBHB in the catalysis (Cho et al., 1999; 
Zhao et al., 1996; 1997). NMR spectroscopic studies combined 
with site-directed mutagenesis have revealed that an LBHB can 
form between Tyr14 O and C3-O of equilenin in the active site 
of D38N (Ha et al., 2001). The strength of the LBHB in C. tes-
tosteroni KSI has been estimated to be at least 7.1 kcal/mol by 
comparing the dissociation rates of the intermediate from the 
Y14F and the D38N mutants (Xue et al., 1991) and by measur-
ing the proton exchange rate of the LBHB over the pH range 
4.3 to 9.0 (Zhao et al., 1996; 1997). The Y14F mutation re-
duced kcat of C. testosteroni KSI by a factor of 5  104 
(Kuliopulos et al., 1989) but that of the D99A mutation only a 
factor of 5  103 (Wu et al., 1997). In addition, Y14F and D99A 
mutants of P. putida KSI (in this paper we number the residues 
of P. putida KSI according to those of C. testosteroni KSI) are 
only 1/2,000 and 1/98 times as active as the wild-type KSI (Kim 
and Choi, 1995; Kim et al., 1997b), respectively; this change 
suggests that by forming LBHBs, Tyr14 contributes to catalysis 
more crucially than does Asp99. 
In this study, we measured the energetic difference be-
tween LBHB and the ordinary hydrogen bond in the active 
site of P. putida KSI. Together with the structural analyses for 
the hydrogen bonds involved in the catalytic reaction of P. 
putida KSI, our NMR spectroscopic studies revealed that the 
putative LBHB between Tyr14 O and C3-O of equilenin ob-
served for D38N KSI was converted to an ordinary hydrogen 
bond by the Y30F/Y55F mutations. The conversion of the 
LBHB to an ordinary hydrogen bond resulted in only marginal 
effects on both catalytic activity of KSI and its binding affinity 
for the intermediate analogue. Our results suggest that the 
contribution of LBHB to catalysis should be only marginal 
compared with that of an ordinary hydrogen bond in the active 
site of KSI. 
MATERIALS AND METHODS 
 
Materials  
5-androstene-3,17-dione (5-AND), androstenolone, equilenin and 
estrone were purchased from Steraloids Inc. (USA). 15N-Labeled 
NH4Cl was purchased from Cambridge Isotope Laboratories Inc. 
(USA). A Superose 12 gel filtration column was purchased from 
Amersham Bioscience (USA). All chemicals for the buffer solution 
were purchased from Sigma (USA). All enzymes for DNA mani-
pulation were purchased from Promega (USA). Oligonucleotides 
were obtained from Genotech Inc. (Korea). 
 
Site-directed mutagenesis, expression and purification of 
mutant KSIs  
Site-directed mutagenesis of Y115F, Y115F/D38N, Y30F/Y55F/ 
Y115F, Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N was 
conducted as described previously (Kim et al., 2000). All muta-
tions were confirmed by sequencing the entire gene of the mu-
tant KSI. Mutant KSIs were overexpressed in Escherichia coli 
BL21(DE3) (Novagen) harboring an expression vector plasmid 
containing the mutant KSI gene, and were purified as described 
previously (Cha et al., 2013; Jang et al., 2004). The purity of KSI 
was confirmed by the presence of only one band in SDS-PAGE. 
 
NMR spectroscopy  
NMR was performed as described previously (Jang et al., 
2006). The NMR sample was adjusted to contain 15 mg/ml KSI 
in 40 mM potassium phosphate buffer at pH 7.0 containing 1 
mM EDTA and 10% DMSO-d6 (dimethyl sulfoxide-d6) (v/v). 
NMR spectra were collected on a spectrometer (Bruker, 
Avance DRX500) equipped with a triple resonance, pulse field 
gradient probe with actively-shielded z-axis gradients, and a 
gradient amplifier unit. A jump-and-return pulse sequence 
(Plateau and Gueron, 1982) was used to suppress the water 
signal. The observed 1H chemical shifts were determined relative 
to that of sodium 2,2-dimethyl-2-silapentane-5-sulfonate as an 
Fig. 1. Reaction catalyzed by ketos-
teroid isomerase. Androste- nolone,
equilenin, and estrone are analo-
gues of substrate, intermediate, and
product of KSI, respectively. The 
proton at C-4 is transferred by Asp
38 to the  side of C-6 during the
isomerization reaction. Both Tyr14
and Asp99 can stabilize the inter-
mediate by forming a hydrogen
bond with the oxyanion of the inter-
mediate. Tyr14 is hydrogen-bonded
to Tyr55 that is in turn hydrogen
bonded to Tyr30 in the P. putida KSI.
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internal standard. All experiments were conducted at 270 K with 
1,000 scans acquired for each spectrum; the relaxation delay 
was 2 s. The spectral width of 20,000 Hz was used in 16,384 
points. Line-broadening of 10 Hz was used when processing the 
data on a workstation (Silicon Graphics, IndyPC) using a 
software program XWIN-NMR v. 1.2. 
 
Determination of dissociation constants for steroid inhibitors  
The affinity of KSI for equilenin, androstenolone, or estrone was 
assessed by measuring the extent of quenching of intrinsic 
tryptophan fluorescence of KSI upon the binding of the respec-
tive steroid. The fluorescence intensities of KSI were measured 
with excitation at 295 nm and emission at 315 nm after adding 
successively various amounts of the steroid dissolved in DMSO 
to the solution of KSI. After correcting the data with appropriate 
dilution factors, dissociation constants were determined by 
fitting the data to the following equation:  
 
[I]t = (F0 - F){KD/(F - F) + [E]/(F0 - F)}, 
 
where [I]t is the concentration of total steroid in the solution, F is 
the fluorescence intensity, F0 is the intensity in the absence of any 
steroid, F

 is the intensity in infinite steroid concentration, [E] is 
the concentration of KSI, and KD is the dissociation constant. 
 
Determination of kinetic parameters, kcat and KM
Enzymatic reactions were initiated by adding KSI to 3 ml of a 
solution containing 34 mM potassium phosphate, pH 7.0, 2.5 
mM EDTA, 3.3% methanol, and the respective amount of a 
steroid substrate, 5-AND. The final concentration of methanol in 
the reaction mixture was 3.3% by volume. All the assays were 
performed at 298 K. Kinetic parameters such as kcat and KM 
were obtained by utilizing Lineweaver-Burk reciprocal plots 
under the assay conditions in which the substrate concentra-
tions were 23.3, 34.9, 58.2, 81.5, and 116.4 M. 
 
Crystallization and structure determination of mutant KSIs 
Crystallization of Y30F/Y55F/Y115F/D38N KSI complexed with 
equilenin was conducted using a hanging drop vapor diffusion 
method as described previously (Cha et al., 2014; Cho et al., 
1999). After 20 mg/ml of the mutant KSI was prepared in a 
buffer containing 40 mM potassium phosphate, pH 7.0, 1 mM 
EDTA, and 20 mM -mercaptoethanol, the 70 l of this solution 
was mixed with 2 l of 10 mM equilenin in dimethyl sulfoxide. 
The optimized crystallization for the mutant KSI was 0.1 M so-
dium acetate, pH 4.5, 0.6 M ammonium acetate, and 30% PEG 
4000. All diffraction data were collected on beamline 5C at Po-
hang Accelerator Laboratory (PAL), Korea. The diffraction images 
were integrated and scaled using the HKL-2000 software pack-
age (Otwinowski and Minor, 1997). The structure of 
Y30F/Y55F/Y115F/D38N complexed with equilenin was deter-
mined by the molecular replacement method using as a search 
model the coordinates of wild-type KSI that had been determined 
previously (Kim et al., 1997a). Model building was performed 
using Coot (Emsley et al., 2010) and refinement was performed 
using Phenix.refine (Afonine et al., 2012). The atomic coordinate 
of Y30F/Y55F/Y115F/D38N complexed with equilenin was depo-
sited at the Protein Data Bank (PDB code 5AI1). 
RESULTS  
Effects of tyrosine-to-phenylalanine substitution(s) in  
P. putida KSI on LBHB 
The Y30F/Y55F/Y115F/D38N mutant KSI that contains no 
A
 
 
 
 
 
 
B
 
 
 
 
 
C
 
 
 
 
 
 
D
 
 
 
 
 
 
E
 
 
 
Fig. 2. 1H NMR spectra of P. putida KSIs. (A) Y30F/D38N at pH 8.5, 
(B) Y55F/D38N at pH 7.0, (C) Y115F/D38N at pH 8.5, (D) 
Y30F/Y55F/D38N at pH 8.5, (E) Y30F/Y55F/Y115F/D38N at pH 7.0, 
which are complexed with equilenin, respectively. The concentration 
of KSI is 10 mg/ml and the concentration of DMSO-d6 10%.  
 
 
 
tyrosine residue other than Tyr14 was prepared to investigate 
the role of Tyr14 in the formation of LBHB without any interfe-
rence from the other three tyrosines (Tyr30, Tyr55, Tyr115) in P. 
putida KSI. A highly deshielded proton resonance was not ob-
served in the downfield region of the NMR spectrum of 
Y30F/Y55F/Y115F/D38N KSI complexed with equilenin (Fig. 2E), 
although Tyr14 still has a hydrogen bonding capability in the ac-
tive site of the mutant. To determine why LBHB is absent in the 
Y30F/Y55F/Y115F/D38N-equilenin complex, the tyrosines at 
positions 30, 55, and 115 in D38N were replaced individually 
with a phenylalanine. The 1H NMR spectra of the Y30F/D38N, 
Y55F/D38N, and Y115F/D38N mutants revealed that LBHB be-
tween Tyr14 O and C3-O of equilenin was not perturbed signifi-
cantly by the Y30F, Y55F, or Y115F mutation (Figs. 2A, 2B, and 
2C). In contrast to the single substitutions of tyrosine with pheny-
lalanine, the highly deshielded proton resonance was not ob-
served in the 1H NMR spectrum of Y30F/Y55F/D38N-equilenin 
complex (Fig. 2D); this result indicates that the absence of LBHB 
in Y30F/Y55F/Y115F/D38N can be attributed to the simultaneous 
replacements of tyrosines with phenylalanines at the positions 30 
and 55 in P. putida KSI.  
 
Affinity of steroid to KSI 
KD values of KSI for equilenin and other steroid inhibitors were 
determined by analyzing the quenching of the intrinsic fluores- 
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Table 1. Effects of the tyrosine-to-phenylalanine substitutions in P. putida KSI on the binding of equilenin and the low-barrier hydrogen bonda  
KSI KD
b
 
(M) 
Highly deshielded
1H resonance (ppm)c 
D38N (3.1  0.6)  10-2 16.8 
Y30F/D38N (0.7  0.1)  10-2 17.6 
Y55F/D38N (0.8  0.2)  10-2 17.9 
Y115F/D38N (0.7  0.2)  10-2 17.1, 16.2 
Y30F/Y55F/D38N (2.5  0.7)  10-1 Not Detected
Y30F/Y55F/Y115F/D38N (3.4  0.7)  10-1 Not Detected 
a The KD measurements and NMR experiments were performed in a buffer containing 40 mM potassium phosphate, 1 mM EDTA, and 10% DMSO. 
b Values are mean ± standard deviation from three independent experiments. 
cOnly the 1H NMR resonance ranging from 16 to 20 ppm, which is regarded as the most unambiguous evidence for the presence of LBHBs in proteins, 
were investigated to identify the presence of LBHB in the mutant KSIs. 
 
 
Table 2. Affinities of D38N and Y30F/Y55F/Y115F/D38N KSI for the steroid inhibitorsa  
Enzyme Steroid KD (M)b Highly deshielded1H resonance (ppm)c 
D38N 
equilenin 
androstenolone 
estrone 
(3.1  0.6)  10-2 
(3.0  0.7)  10-1 
(1.1  0.4)  10-1 
16.8 
16.8 
18.0 
Y30F/Y55F/Y115F/D38N 
equilenin 
androstenolone
estrone 
(3.4  0.7)  10-1 
3.2  0.3 
1.0  0.2 
Not Detected 
Not Detected 
Not Detected 
a Measurements were performed in 10 mM potassium phosphate buffer containing 10% dimethyl sulfoxide. 
bValues are mean  standard deviation from three independent experiments. 
cOnly the 1H NMR resonances ranging from 16 to 20 ppm were investigated to identify the presence of LBHB in KSI. 
 
 
 
cence of the enzyme while varying the steroid concentration. 
The conditions such as the concentration of DMSO in the fluo-
rescence measurements were the same as those in the NMR 
experiments. When the mutation of Y30F, Y55F or Y115F was 
imposed in addition to D38N, the KD values of the mutant KSIs 
were only approximately doubled relative to that of D38N (Table 
1). The KD values of the Y30F/Y55F/D38N and Y30F/ 
Y55F/Y115F/D38N mutants whose 1H NMR spectra exhibited 
no highly deshielded proton resonance in the downfield region 
around 16 ppm, were increased by factors of 8.1 and 11, re-
spectively (Table 1). 
The KD values of D38N and Y30F/Y55F/Y115F/D38N were 
also determined for the steroid inhibitors androstenolone and 
estrone (Fig. 3). When androstenolone or estrone was bound to 
D38N KSI, a highly deshielded proton resonance at 16.8 or 
18.0 ppm respectively, was observed in the downfield of the 
1H NMR spectrum. In contrast, the highly deshielded proton 
resonance was not observed in the 1H NMR spectrum of 
Y30F/Y55F/Y115F/D38N complexed with androstenolone or 
estrone, respectively. Even if the A and B ring structures of 
androstenolone and estrone are very different from those of 
equilenin, the additional tyrosine-to-phenylalanine substitutions 
reduced the binding affinities of D38N KSI for these steroid 
inhibitors to a similar extent as that for equilenin (Table 2). 
 
Kinetic analyses 
The kcat and KM values of the mutant KSIs for a steroid sub-
strate (5-AND) were compared with those of the wild type (Ta-
ble 3). A previous investigation on the hydrogen bond network 
(Kim et al., 2000) revealed that the kcat values of Y30F and 
Y55F were decreased by factors of 1.2 and 6 respectively rela- 
 
 
 
 
 
 
Fig. 3. Structures of important steroid inhibitors of KSI. All the stero-
id inhibitors have the hydroxyl group at the C3 position that can 
form a hydrogen bond with Tyr14 and Asp99. The binding affinities 
of the steroid inhibitors for D38N were lowered to the similar extent 
by the additional Y30F/Y55F/Y115F mutations irrespective of the 
structural differences among the inhibitors. 
 
 
 
tive to that of the wild-type KSI. These kcat values are signify-
cantly higher than that of Y14F which is lower by a factor of 
103.2 than that of the wild-type KSI. In addition, the replace-
ment of Tyr115 with a phenylalanine also resulted in decrease 
in kcat by a factor of 1.5. These results indicate that Tyr30, 
Tyr55 and Tyr115 are not critically essential for catalysis by P. 
putida KSI even if the contribution of Tyr55 to catalysis is 
somewhat significant. In spite of the absence of LBHB in the 
1H NMR spectra, Y30F/Y55F and Y30F/Y55F/Y115F mutant 
KSIs exhibited relatively high catalytic activities with the kcat 
values decreased marginally by factors of 2.0 and 1.7, re-
spectively, compared with the wild type. These kcat values 
were even significantly higher than that of Y55F whose 1H 
NMR spectrum exhibited a highly deshielded proton reson-
ance at 17.9 ppm, which is similar to that of the wild-type 
enzyme.
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Table 3. Kinetic parameters of the wild type and its mutant KSIsa  
Enzyme 
kcat 
(s-1) 
KM 
(M) 
kcat / KM 
(M-1s-1) 
Relative 
kcat 
WT b
Y14F c 
Y30F d 
Y55F d 
Y115F  
Y30F/Y55F d 
Y30F/Y55F/Y115F 
(21.2  0.8)  103 
13.3  0.6 
(17.8  0.1)  103 
(35.1  0.6)  102 
(14.5  0.4)  103 
(10.7  0.4)  103 
(12.2  0.2)  103 
49.9  1.3 
17.1  3.1  
55.2  2.0 
23.0  1.0 
41.7  2.0 
50.2  5.5 
77.3  5.6 
4.3  108 
7.8  105 
3.3  108 
1.5  108 
3.5  108 
2.1  108 
1.6  108 
1 
10-3.2 
0.84 
0.17 
0.68 
0.50 
0.57 
a The assays were performed in a buffer containing 34 mM potassium phosphate, pH 7.0, 2.5 mM EDTA and 3.3 % methanol. bData from Kim et al. (1999). 
c Data from Kim and Choi (1995). dData from Kim et al. (2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three-dimensional structure of Y30F/Y55F/Y115F/D38N  
complexed with equilenin 
The binding mode of equilenin in the active site of Y30F/ 
Y55F/Y115F/D38N was investigated using X-ray crystallogra-
phy. The crystals of Y30F/Y55F/Y115F/D38N-equilenin com-
plex were found to belong to the C2221 space group with unit 
cell dimensions of a = 35.2 Å, b = 95.8 Å and c = 73.5 Å. The 
final structure of Y30F/Y55F/Y115F/D38N-equilenin complex 
was determined at 2.1-Å resolution. The crystallographic statis-
tics for the final structure are shown in Supplementary Table 1. 
The crystal structure of the mutant revealed that the benzyl side 
chains of the substituted phenylalanines were located at the 
positions similar to those of the corresponding tyrosine residues 
in D38N but without the hydroxyl groups (Fig. 4). The hydrogen 
bond geometry between equilenin and catalytic residues in 
Y30F/Y55F/Y115F/D38N was very similar to that in D38N. The 
bound steroid was located in the active site of the mutant with 
the steroid A-ring approaching Tyr14 and Asp99 (Fig. 4; Sup-
plementary Fig. 1). Three catalytic residues, Tyr14, Asp38 and 
Asp99, which are critical for the catalytic activity of KSI, were 
found to be located at positions similar to those in D38N. Tyr14 
O was involved in a hydrogen bond with C3-O of equilenin 
with a distance of 2.80 Å in the active site of Y30F/Y55F/ 
Y115F/D38N complexed with the steroid. 
 
DISCUSSION 
 
Using KSI as a model system, we investigated the nature and 
origin of stabilization of the reaction intermediate or the transi-
tion-state to explain the enormous rate enhancement of the 
enzyme-catalyzed reaction over the non-enzymatic reaction. 
Especially, we investigated the proposition that LBHB can pro-
vide an additional energetic contribution to enzyme catalysis 
compared with the ordinary hydrogen bond. In P. putida KSI, 
LBHB was proposed to be formed between Tyr14 O and C3-
O of equilenin, an intermediate analogue, in the active site of 
D38N KSI, as revealed by NMR spectroscopic studies com-
bined with site-directed mutagenesis (Ha et al., 2001). The ab-
sence of a highly deshieled proton resonance at ~16 ppm in the 
1H NMR spectrum of Y30F/Y55F/Y115F/D38N KSI complexed 
with equilenin clearly indicates that the LBHB between Tyr14 O 
and C3-O of the steroid does not exist in the active site of the 
mutant KSI. In addition, the distance between Tyr14 O and 
C3-O of equilenin was changed. The distance in the Y30F/ 
Y55F/Y115F/D38N KSI was 2.80 Å, whereas that in D38N KSI 
was 2.57 Å (Fig. 4). Considering that the major features of a 
LBHB are a distance 	 2.65 Å between a proton donor and a 
proton acceptor or a 16- to 20-ppm 1H NMR chemical shift in 
the downfield region, or both (Frey et al., 1994; Fuhrmann et al., 
2006), the putative LBHB might be replaced by an ordinary 
hydrogen bond in Y30F/Y55F/Y115F/D38N KSI. 
Tyr14 O forms a hydrogen bond with Tyr55 O that is in 
turn hydrogen-bonded to Tyr30 O in the active site of P. putida 
KSI (Fig. 1). Tyr55 may have an important function in the forma-
tion of LBHB between Tyr14 O and C3-O of equilenin by pro-
viding a hydrogen bond to Tyr14 and consequently affecting the 
Fig. 4. Crystal Structure of Y30F/Y55F/
Y115F/D38N complexed with equilenin.
All the backbone atoms were utilized to
superimpose the structures of D38N (PDB
code 1E3N) and Y30F/Y55F/Y115F/
D38N, which are complexed with
equilenin. The active-site residues of
D38N are colored in gray and those of
Y30F/Y55F/Y115F/D38N in black. The
hydrogen bonds are indicated by dotted
lines. The PyMOL program was used to
display the structures. 
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pKa of Tyr14 through the hydrogen bond. The crystal structure 
of Y55F P. putida KSI (Kim et al., 2000) revealed a new hydro-
gen bond between Tyr14 O and Tyr30 O; this bond compen-
sates for the loss of a hydrogen bond that was provided by 
Tyr55. Simultaneous replacements of Tyr30 and Tyr55 with 
phenylalanines in P. putida KSI can both disrupt the hydrogen 
bond between Tyr14 and Tyr55 and change the local dielectric 
constant of the catalytic site of the mutant KSI; both of these 
changes can influence the pKas of the hydrogen bond partners 
of the LBHB. Our data suggest that the hydrogen bond be-
tween Tyr14 and Tyr55 could be essential to enable the forma-
tion of LBHB in the active site of KSI. 
The 1H NMR spectrum and crystal structure of the 
Y30F/Y55F/Y115F/D38N KSI complexed with equilenin re-
vealed that LBHB between Tyr14 O and C3-O of the steroid in 
D38N was replaced by an ordinary hydrogen bond. The affini-
ties of the Y30F/Y55F/Y115F/D38N KSI for steroid inhibitors 
(androstenolone, estrone, equilenin), were lower by factors of 
9.1-11 than those of the D38N KSI; this change corresponds to 
a decrease of only 1.3-1.4 kcal/mol in binding energy. This de-
crease in the binding energy could be attributed to the addition-
al contribution of the LBHB to the steroid binding compared with 
that of the ordinary hydrogen bond in the active site of KSI. In 
addition, the catalytic activities of the Y30F/Y55F and 
Y30F/Y55F/Y115F KSIs were only slightly decreased com-
pared with that of the wild-type enzyme in spite of the conver-
sion of LBHB to an ordinary hydrogen bond in these mutant 
KSIs. Similar observations have also been reported in other 
enzyme systems (Stratton et al., 2001; Zhao et al., 2004). A 
serine protease, subtilisin BPN’ demonstrated a downfield NMR 
resonance near 18 ppm that was considered to originate from 
LBHB in the wild-type subtilisin (Stratton et al., 2001). This cha-
racteristic downfield chemical shift is not present in the D32C 
subtilisin, but this mutation had only moderate effects on the 
catalytic activity of subtilisin; this observation suggests that an 
LBHB does not provide exceptionally high stabilization energy 
compared with an ordinary hydrogen bond (Stratton et al., 
2001). Carboxymethyldethia coenzyme A, an inhibitor of citrate 
synthase, forms an LBHB with Asp375 of the enzyme, whereas 
the primary amine analog of the coenzyme A forms an ordinary 
hydrogen bond (Usher et al., 1994). Only the extra energy of 
1.8 kcal/mol has been attributed to the LBHB in the active site 
of citrate synthase by comparing the binding affinities between 
the carboxyl analog and the primary amine analog of the coen-
zyme A (Usher et al., 1994). A putative LBHB between Asp56 
and a phosphate was also found in the crystal structures of 
phosphate binding protein (PBP) complexes determined at 
resolutions of 0.98 and 1.05 Å. The D56N mutation that con-
verts the LBHB into an ordinary hydrogen bond resulted in no 
profound effect on the binding affinity of PBP for a phosphate 
(Wang et al., 1997). These results are consistent with the idea 
that the additional binding energy and contribution to catalysis 
provided by an LBHB are not significant compared to those by 
the ordinary hydrogen bond as observed in the KSI mutants, 
Y30F/Y55F/D38N and Y30F/Y55F/Y115F/D38N.  
The proton transfer by KSI from the C4 proton of 5-AND with 
pKa of 12.7 to the carboxylate oxygen of Asp38 with pKa of 4.5 
is energetically unfavorable in solution; calculation indicates 
that it requires 11 kcal/mol of energy (Ha et al., 2000). This high 
energetic barrier to proton abstraction during the reaction of KSI 
should be overcome by a very strong interaction; this require-
ment seems to contradict our observation that LBHB provides 
only moderate stabilization of the intermediate. However, the 
energetic barrier in the reaction of KSI might be much smaller 
than 11 kcal/mol, because the pKa difference between the car-
boxylate of Asp38 and the C4-proton of the steroid substrate 
can be significantly reduced in the active site of KSI by pKa 
perturbation (Ha et al., 2000); crystal structure of wild-type P. 
putida KSI complexed with deoxycholate, a competitive inhibitor 
of KSI, revealed that the isopentanoate moiety on the steroid D 
ring was involved in hydrogen bonds with the three catalytic 
residues, Tyr14, Asp38 and Asp99. Analysis of the hydrogen 
bonding geometry indicated that Asp38, for which estimated 
pKa = 4.5 (Zhao et al., 1995), might be in the protonated state 
at pH 6.7 for the formation of the energetically favorable hydro-
gen bonds between the inhibitor and catalytic residues (Ha et 
al., 2000). Assuming that the stabilization energy of the inter-
mediate can be significantly reduced due to the pKa perturba-
tion of a catalytic base (Asp38), explanation of the diffusion 
controlled reaction rate of KSI may not require an unusually 
strong interaction provided by LBHB. The nature of hydrogen 
bonding in the stabilization of the intermediate was investigated 
previously in the reaction of KSI by analyzing the binding of 
substituted phenols to the D38N KSI (Petrounia and Pollack, 
1998). The negative charge in the D38N KSI-phenol complex 
was localized almost exclusively on the bound ligand, with very 
little charge transfer to the hydrogen bonding groups of the 
enzyme (Petrounia and Pollack, 1998); this localization is cha-
racteristic of ordinary hydrogen bonds. These results indicate 
that the ordinary hydrogen bond rather than an LBHB would be 
sufficient to account for the stabilization of the dienolate inter-
mediate during the reaction of KSI. 
In conclusion, we have shown that the conversion of LBHB to 
an ordinary hydrogen bond resulted in only marginal decrease 
of the catalytic activity and the binding affinity for the interme-
diate analogue in P. putida KSI. Our results indicate that LBHB 
seems to provide only moderate stabilization of the interme-
diate in the reaction catalyzed by P. putida KSI. Consequently, 
the enormous rate enhancement achieved by KSI is not attri-
buted solely to the presence of LBHB in the active site. Rather, 
the enhancement may be due to the sum of many different 
contributions including hydrogen bonds, electrostatic and hy-
drophobic interactions, and positioning of the substrate on the 
enzyme. 
Note: Supplementary information is available on the Molecules 
and Cells website (www.molcells.org). 
ACKNOWLEDGMENTS 
This research was supported by a grant from the National R & 
D Program for Cancer Control, Ministry for Health and Welfare, 
Republic of Korea (1320240). This study was also supported by 
the National Research Foundation of Korea (NRF) grant funded by 
the Korea government (MSIP) (NRF-2014R1A2A2A01002931). 
We thank the staff at 5C beamline, Pohang Accelerator Labora-
tory, Korea, for help with the data collection, and Jae-Hee 
Jeong and Dr. Yeon-Gil Kim for technical assistance and help-
ful discussion. 
REFERENCES 
Afonine, P.V., Grosse-Kunstleve, R.W., Echols, N., Headd, J.J., 
Moriarty, N.W., Mustyakimov, M., Terwilliger, T.C., Urzhumtsev, 
A., Zwart, P.H., and Adams, P.D. (2012). Towards automated 
crystallographic structure refinement with phenix.refine. Acta 
Crystallogr. D Biol. Crystallogr. 68, 352-367. 
Ash, E.L., Sudmeier, J.L., De Fabo, E.C., and Bachovchin, W.W. 
(1997). A low-barrier hydrogen bond in the catalytic triad of 
serine proteases? Theory versus experiment. Science 278, 
Contribution of LBHB to Catalysis Is Not Significant in KSI 
Do Soo Jang et al. 
 
G
http://molcells.org  Mol. Cells  415 
G
G
1128-1132. 
Cha, H.J., Jang, D.S., Kim, Y.G., Hong, B.H., Woo, J.S., Kim, K.T., 
and Choi, K.Y. (2013). Rescue of deleterious mutations by the 
compensatory Y30F mutation in ketosteroid isomerase. Mol. 
Cells 36, 39-46. 
Cha, H.J., Jeong, J.H., Rojviriya, C., and Kim, Y.G. (2014). Structure 
of Putrescine Aminotransferase from Escherichia coli Provides 
Insights into the Substrate Specificity among Class III 
Aminotransferases. PLoS One 9, e113212. 
Cho, H.S., Choi, G., Choi, K.Y., and Oh, B.H. (1998). Crystal 
structure and enzyme mechanism of Delta 5-3-ketosteroid 
isomerase from Pseudomonas testosteroni. Biochemistry 37, 
8325-8330. 
Cho, H.S., Ha, N.C., Choi, G., Kim, H.J., Lee, D., Oh, K.S., Kim, 
K.S., Lee, W., Choi, K.Y., and Oh, B.H. (1999). Crystal structure 
of delta(5)-3-ketosteroid isomerase from Pseudomonas 
testosteroni in complex with equilenin settles the correct 
hydrogen bonding scheme for transition state stabilization. J. 
Biol. Chem. 274, 32863-32868.  
Cleland, W.W., and Kreevoy, M.M. (1994). Low-barrier hydrogen 
bonds and enzymic catalysis. Science 264, 1887-1890. 
Cleland, W.W., Frey, P.A., and Gerlt, J.A. (1998). The low barrier 
hydrogen bond in enzymatic catalysis. J. Biol. Chem. 273, 
25529-25532. 
Emsley, P., Lohkamp, B., Scott, W.G., and Cowtan, K. (2010). 
Features and development of Coot. Acta Crystallogr. D Biol. 
Crystallogr. 66, 486-501. 
Frey, P.A., Whitt, S.A., and Tobin, J.B. (1994). A low-barrier 
hydrogen bond in the catalytic triad of serine proteases. Science
264, 1927-1930. 
Fuhrmann, C.N., Daugherty, M.D., and Agard, D.A. (2006). 
Subangstrom crystallography reveals that short ionic hydrogen 
bonds, and not a His-Asp low-barrier hydrogen bond, stabilize 
the transition state in serine protease catalysis. J. Am. Chem. 
Soc. 128, 9086-9102. 
Gerlt, J.A., Kozarich, J.W., Kenyon, G.L., and Gassman, P.G. (1991). 
Electrophilic catalysis can explain the unexpected acidity of 
carbon acids in enzyme-catalyzed reactions. J. Am. Chem. Soc.
113, 9667-9669. 
Gerlt, J.A., and Gassman, P.G. (1993). Understanding the rates of 
certain enzyme-catalyzed reactions: proton abstraction from 
carbon acids, acyl-transfer reactions, and displacement 
reactions of phosphodiesters. Biochemistry 32, 11943-11952.  
Ha, N.C., Kim, M.S., Lee, W., Choi, K.Y., and Oh, B.H. (2000). 
Detection of large pKa perturbations of an inhibitor and a 
catalytic group at an enzyme active site, a mechanistic basis for 
catalytic power of many enzymes. J. Biol. Chem. 275, 41100-
41106. 
Ha, N.C., Choi, G., Choi, K.Y., and Oh, B.H. (2001). Structure and 
enzymology of Delta5-3-ketosteroid isomerase. Curr. Opin. 
Struct. Biol. 11, 674-678. 
Jang, D.S., Cha, H.J., Cha, S.S., Hong, B.H., Ha, N.C., Lee, J.Y., 
Oh, B.H., Lee, H.S., and Choi, K.Y. (2004). Structural double-
mutant cycle analysis of a hydrogen bond network in ketosteroid 
isomerase from Pseudomonas putida biotype B. Biochem. J.
382, 967-973. 
Jang, D.S., Lee, H.J., Lee, B., Hong, B.H., Cha, H.J., Yoon, J., Lim, 
K., Yoon, Y.J., Kim, J., Ree, M., et al. (2006). Detection of an 
intermediate during the unfolding process of the dimeric 
ketosteroid isomerase. FEBS Lett. 580, 4166-4171. 
Kim, S.W., and Choi, K.Y. (1995). Identification of active site 
residues by site-directed mutagenesis of delta 5-3-ketosteroid 
isomerase from Pseudomonas putida biotype B. J. Bacteriol.
177, 2602-2605. 
Kim, S.W., Cha, S.S., Cho, H.S., Kim, J.S., Ha, N.C., Cho, M.J., Joo, 
S., Kim, K.K., Choi, K.Y., and Oh, B.H. (1997a). High-resolution 
crystal structures of delta5-3-ketosteroid isomerase with and 
without a reaction intermediate analogue. Biochemistry 36, 
14030-14036. 
Kim, S.W., Joo, S., Choi, G., Cho, H.S., Oh, B.H., and Choi, K.Y. 
(1997b). Mutational analysis of the three cysteines and active-site 
aspartic acid 103 of ketosteroid isomerase from Pseudomonas 
putida biotype B. J. Bacteriol. 179, 7742-7747. 
Kim, D.H., Nam, G.H., Jang, D.S., Choi, G., Joo, S., Kim, J.S., Oh, 
B.H., and Choi, K.Y. (1999). Roles of active site aromatic 
residues in catalysis by ketosteroid isomerase from 
Pseudomonas putida biotype B. Biochemistry 38, 13810-13819. 
Kim, D.H., Jang, D.S., Nam, G.H., Choi, G., Kim, J.S., Ha, N.C., Kim, 
M.S., Oh, B.H., and Choi, K.Y. (2000). Contribution of the 
hydrogen-bond network involving a tyrosine triad in the active 
site to the structure and function of a highly proficient ketosteroid 
isomerase from Pseudomonas putida biotype B. Biochemistry
39, 4581-4589. 
Kuliopulos, A., Mildvan, A.S., Shortle, D., and Talalay, P. (1989). 
Kinetic and ultraviolet spectroscopic studies of active-site mutants 
of delta 5-3-ketosteroid isomerase. Biochemistry 28, 149-159. 
Otwinowski, Z., and Minor, W. (1997). Processing of X-ray 
diffraction data collected in oscillation mode. Meth. Enzymol.
276, 307-326. 
Perrin, C.L. (2010). Are short, low-barrier hydrogen bonds unusually 
strong? Acc. Chem. Res. 43, 1550-1557. 
Petrounia, I.P., and Pollack, R.M. (1998). Substituent effects on the 
binding of phenols to the D38N mutant of 3-oxo-delta5-steroid 
isomerase. A probe for the nature of hydrogen bonding to the 
intermediate. Biochemistry 37, 700-705. 
Plateau, P., and Gueron, M. (1982). Exchangeable proton NMR 
without base-line distorsion, using new strong-pulse sequences. 
J. Am. Chem. Soc. 104, 7310-7311. 
Pollack, R.M. (2004). Enzymatic mechanisms for catalysis of 
enolization: ketosteroid isomerase. Bioorg. Chem. 32, 341-353. 
Pollack, R.M., Thornburg, L.D., Wu, Z.R., and Summers, M.F. 
(1999). Mechanistic insights from the three-dimensional 
structure of 3-oxo-Delta(5)-steroid isomerase. Arch. Biochem. 
Biophys. 370, 9-15. 
Schutz, C.N., and Warshel, A. (2004). The low barrier hydrogen 
bond (LBHB) proposal revisited: the case of the Asp... His pair in 
serine proteases. Proteins 55, 711-723. 
Shan, S.O., Loh, S., and Herschlag, D. (1996). The energetics of 
hydrogen bonds in model systems: implications for enzymatic 
catalysis. Science 272, 97-101. 
Stratton, J.R., Pelton, J.G., and Kirsch, J.F. (2001). A novel 
engineered subtilisin BPN' lacking a low-barrier hydrogen bond 
in the catalytic triad. Biochemistry 40, 10411-10416. 
Usher, K.C., Remington, S.J., Martin, D.P., and Drueckhammer, D.G. 
(1994). A very short hydrogen bond provides only moderate 
stabilization of an enzyme-inhibitor complex of citrate synthase. 
Biochemistry 33, 7753-7759. 
Wang, Z., Luecke, H., Yao, N., and Quiocho, F.A. (1997). A low energy 
short hydrogen bond in very high resolution structures of protein 
receptor--phosphate complexes. Nat. Struct. Biol. 4, 519-522. 
Warshel, A., and Papazyan, A. (1996). Energy considerations show 
that low-barrier hydrogen bonds do not offer a catalytic 
advantage over ordinary hydrogen bonds. Proc. Natl. Acad. Sci. 
USA 93, 13665-13670. 
Wu, Z.R., Ebrahimian, S., Zawrotny, M.E., Thornburg, L.D., Perez-
Alvarado, G.C., Brothers, P., Pollack, R.M., and Summers, M.F. 
(1997). Solution structure of 3-oxo-delta5-steroid isomerase. 
Science 276, 415-418. 
Xue, L.A., Talalay, P., and Mildvan, A.S. (1991). Studies of the 
catalytic mechanism of an active-site mutant (Y14F) of delta 5-3-
ketosteroid isomerase by kinetic deuterium isotope effects. 
Biochemistry 30, 10858-10865. 
Zhang, C. (2007). Low-barrier hydrogen bond plays key role in 
active photosystem II--a new model for photosynthetic water 
oxidation. Biochim. Biophys. Acta. 1767, 493-499. 
Zhao, Q., Li, Y.K., Mildvan, A.S., and Talalay, P. (1995). Ultraviolet 
spectroscopic evidence for decreased motion of the active site 
tyrosine residue of delta 5-3-ketosteroid isomerase by steroid 
binding. Biochemistry 34, 6562-6572. 
Zhao, Q., Abeygunawardana, C., Talalay, P., and Mildvan, A.S. 
(1996). NMR evidence for the participation of a low-barrier 
hydrogen bond in the mechanism of delta 5-3-ketosteroid 
isomerase. Proc. Natl. Acad. Sci. USA 93, 8220-8224. 
Zhao, Q., Abeygunawardana, C., Gittis, A.G., and Mildvan, A.S. 
(1997). Hydrogen bonding at the active site of delta 5-3-
ketosteroid isomerase. Biochemistry 36, 14616-14626. 
Zhao, L., Liao, H., and Tsai, M.D. (2004). The catalytic role of 
aspartate in a short strong hydrogen bond of the Asp274-His32 
catalytic dyad in phosphatidylinositol-specific phospholipase C 
can be substituted by a chloride ion. J. Biol. Chem. 279, 31995-
32000. 
 
